// App-Quantinova.ai

Tu1354 : Efficacy and Patient Tolerability of Split Dose 2L vs. Split Dose 4L Peglyte: a Prospective Randomized Controlled Trial

Researchers

Presenter

  • George Ou

Principal Investigators

  • Andrew M. Round

  • Jessica Tong

  • Ricky W. Kwok

  • Cherry Galorport

  • Hin Hin Ko

  • Eric C. Lam

  • Brian Bressler

  • Jennifer J. Telford

  • Robert A. Enns

Medical Centers

  • Gastroenterology, St. Paul's Hospital, Vancouver, British Columbia, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Inflammatory bowel disease

  • Constipation

Biomarkers

  • N/A

Drug/Treatment

  • Sodium picosulfate

  • Ascorbic acid

  • Bisacodyl

  • Moviprep

  • PEG 3350

Outcome

  • N/A

Study Design

  • non inferiority

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved